Start a live chat
1-800-870-4800
The NAD+ precursor family —
NMN, NR, niacin,
and where each one sits.
The body has several routes to NAD+ — and several molecules that can serve as starting points for those routes. NMN, nicotinamide riboside, nicotinic acid, and nicotinamide each belong to the same molecular family and each feeds into the NAD+ biosynthesis system. But they enter at different points, require different enzymatic steps, and travel different paths to the same destination. Understanding those differences is the foundation of how this field thinks about NAD+ biology.
I
One destination,
several paths to reach it.
NAD+ cannot be meaningfully supplemented by consuming NAD+ directly in large quantities — the molecule must be produced inside cells by the body's own biosynthesis machinery. Which means that any approach to supporting NAD+ availability works through precursors: molecules that the body can absorb, transport to tissues, and convert into NAD+ through the enzymatic pathways it has available.
The precursor family that has attracted the most attention in longevity biology draws almost entirely from a single chemical lineage — the vitamin B3 compounds and their downstream derivatives. Nicotinic acid (niacin), nicotinamide, nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN) are all related to one another structurally, all capable of contributing to the NAD+ pool, and all studied in the context of NAD+ biology. Yet they are meaningfully distinct molecules — different in size, different in the specific pathway they feed, different in how many enzymatic steps stand between them and NAD+, and different in the research history that surrounds each one.
What follows is a reference-style overview of each member of this family: what it is, where it comes from, how the body handles it, and what its specific relationship to the NAD+ biosynthesis system looks like. This is not a comparison of efficacy — the evidence base for each molecule is still developing and varies significantly in depth and scope across the family. It is a structural map of a molecular family that sits at the center of one of the most actively studied areas in longevity biology today.
They share a family.
They share a destination.
What differs is the path —
and the body's capacity
to walk it as it ages.
The NAD+ Precursor Family
Four molecules. One destination.
Different paths through the body.
Each card describes one member of the NAD+ precursor family — what it is, where it enters the biosynthesis system, and the key characteristics that define how the body works with it. No efficacy comparisons are made here. The science of each molecule continues to develop.
Molecular class
Nucleotide — pyridine ring with ribose sugar and phosphate group
Molecular weight
334 daltons — the largest member of the B3-derived precursor family
Pathway entry point
Salvage Pathway — enters downstream of NAMPT, the rate-limiting step
Steps to NAD+
One — converted by NMNAT directly to NAD+ inside cells
Natural occurrence
Produced endogenously by NAMPT from nicotinamide; trace amounts in certain foods including edamame, broccoli, avocado, and dairy
Research context
Extensive animal literature; human pharmacokinetic data confirmed; multiple clinical trials active across aging, metabolic, and cardiovascular biology domains
Molecular class
Nucleoside — pyridine ring with ribose sugar, no phosphate group
Molecular weight
255 daltons — smaller than NMN, larger than nicotinamide
Pathway entry point
Salvage Pathway — converted to NMN by NRK enzymes, then NMN to NAD+ by NMNAT
Steps to NAD+
Two — NRK phosphorylates NR to NMN; NMNAT then converts NMN to NAD+
Natural occurrence
Found in trace amounts in milk and certain foods; also produced in some metabolic contexts within the body
Research context
Earlier human clinical data than NMN; multiple published human trials; well-characterized pharmacokinetics; active area of NAD+ precursor research
Molecular class
Pyridine-3-carboxylic acid — the simplest member of the B3 family
Molecular weight
123 daltons — the smallest NAD+ precursor in this family
Pathway entry point
Preiss-Handler Pathway — converted through NaMN and NaAD to NAD+; does not pass through NMN
Steps to NAD+
Three — via NAPRT to NaMN, then to NaAD, then NMNAT converts to NAD+
Natural occurrence
Widely available in animal products, legumes, nuts, and fortified foods; one of the most established dietary B3 sources
Research context
The most historically studied B3 compound; extensive cardiovascular and metabolic literature; associated with a flushing response at higher doses via a distinct receptor pathway
Molecular class
Pyridine-3-carboxamide — the amide form of niacin, structurally distinct despite same B3 classification
Molecular weight
122 daltons — virtually the same size as nicotinic acid but chemically different
Pathway entry point
Salvage Pathway — NAMPT converts nicotinamide to NMN (the rate-limiting step); NMNAT then converts NMN to NAD+
Steps to NAD+
Two — but critically, the first step is the NAMPT-dependent rate-limiting conversion whose efficiency declines with age
Natural occurrence
Released endogenously as a byproduct every time NAD+ is consumed by sirtuins, PARPs, or CD38; also present in meat, fish, and plant foods
Research context
Widely used topically in skincare; studied in metabolic and neurological contexts; the upstream substrate whose NAMPT-dependent conversion to NMN is the central bottleneck of the aging NAD+ system
II
What the family shares —
and what makes each member distinct.
All four members of this family share a structural core — the pyridine ring that defines the vitamin B3 molecular lineage — and all four can contribute to the NAD+ pool through their respective biosynthesis pathways. That shared destination has made them all objects of study in the NAD+ longevity biology literature, and all four have generated meaningful bodies of research.
What differentiates them is position and path. Nicotinic acid enters through the Preiss-Handler route — an efficient three-step process that bypasses NMN entirely and has been studied most extensively in the context of cardiovascular and metabolic biology, where the niacin literature stretches back decades. Nicotinamide and NMN both feed the Salvage Pathway — the dominant NAD+ production route in adult tissue — with nicotinamide as the upstream substrate and NMN as the downstream product of the rate-limiting NAMPT conversion. NR occupies a middle position: it enters the Salvage Pathway one step before NMN, converted by NRK enzymes to NMN before the final NMNAT-catalyzed conversion to NAD+.
The significance of these positional differences is sharpest in the context of aging. The Salvage Pathway's rate-limiting step — NAMPT converting nicotinamide to NMN — declines with age. This means that nicotinamide, which must cross that bottleneck, faces a progressively less efficient conversion as the body ages. NR, sitting one step downstream of nicotinamide, must still be phosphorylated to NMN before the final conversion — a step that depends on NRK enzyme activity. NMN, already past the NAMPT bottleneck, requires only the NMNAT-mediated final step that aging affects less directly. Understanding where each precursor sits relative to the age-affected enzymatic landscape is part of how the longevity biology community thinks about this family of molecules.
Pathway Position Summary
How each precursor relates
to the age-affected enzymatic landscape.
Nicotinic Acid (NA)
Preiss-Handler — parallel route, independent of the Salvage bottleneck
NA feeds the Preiss-Handler pathway through NAPRT — an enzyme whose activity is distinct from NAMPT and does not show the same age-related decline pattern. Its route to NAD+ is three steps and bypasses NMN entirely. It is the oldest-studied member of this family and the one with the most extensive historical clinical literature.
Nicotinamide (NAM)
Salvage Pathway — upstream of the rate-limiting NAMPT step
NAM is the natural substrate for NAMPT — it sits directly before the Salvage Pathway's rate-limiting bottleneck. In younger tissue, NAMPT efficiently converts NAM to NMN. As NAMPT activity declines with age, the conversion slows. NAM is also the molecule released every time NAD+ is consumed in the body — making it the perpetual raw material of the NAD+ recycling system.
Nicotinamide Riboside (NR)
Salvage Pathway — enters via NRK, one step before NMN
NR bypasses the NAMPT step but requires NRK (nicotinamide riboside kinase) phosphorylation to become NMN before the final NAD+ conversion. It was the first nucleoside-form NAD+ precursor to be studied extensively in humans, and its pharmacokinetics are well-characterized. Its pathway relationship to NMN makes it the most structurally proximate member of the family to NMN.
NMN
Salvage Pathway — downstream of NAMPT, one step from NAD+
NMN enters the Salvage Pathway at the step immediately after NAMPT's rate-limiting conversion — already phosphorylated, requiring only NMNAT for the final NAD+ synthesis. It is the terminal precursor in the dominant adult NAD+ production route and the one whose position relative to the age-affected NAMPT bottleneck has made it a central focus of longevity-oriented NAD+ biology.
The Family in Numbers
What defines the NAD+
precursor family structurally.
3
Distinct biosynthesis pathways used by the four family members — de novo, Preiss-Handler, and Salvage
The four principal NAD+ precursors feed into three separate biosynthesis routes. Tryptophan uses de novo. Nicotinic acid uses Preiss-Handler. Nicotinamide, NR, and NMN all enter the Salvage Pathway — but at different points along it. This means that the same cellular NAD+ pool can be supplied through fundamentally different enzymatic machinery depending on which precursor is present.
2.7×
Molecular weight range across the family — from nicotinamide at 122 daltons to NMN at 334 daltons
The structural differences within this family are significant despite shared chemistry. The addition of ribose to nicotinamide creates NR. The further addition of phosphate to NR creates NMN. Each addition changes the molecule's size, charge, membrane permeability, and the specific transporter or enzyme needed to handle it — which is part of why each member of the family has a distinct absorption and conversion profile.
1
Final enzymatic step shared by all Salvage Pathway precursors — NMNAT converting NMN to NAD+
Whether the starting point is nicotinamide, NR, or NMN itself, the final step to NAD+ in the Salvage Pathway is always NMNAT converting NMN to NAD+. All roads through the Salvage Pathway converge on NMN before the destination. This convergence point is why NMN occupies its specific position in the longevity biology literature — it is where every Salvage Pathway precursor must arrive before NAD+ can be made.
III
A family worth understanding
on its own terms.
The NAD+ precursor family is not a ranking exercise. Each member has a different history, a different research profile, and a different set of characteristics that define how the body works with it. Nicotinic acid has decades of human data behind it in metabolic and cardiovascular research. Nicotinamide riboside was the first nucleoside-form NAD+ precursor to generate substantial human clinical evidence. NMN is the most recently studied in humans but has generated rapid clinical interest on the basis of a compelling preclinical record. Nicotinamide is the universal substrate — the molecule the body always has, always recycles, and always depends on.
What they share is more important than what distinguishes them: a common destination in the NAD+ pool, a common biological rationale in the context of age-related NAD+ decline, and a common place in a field of research that continues to generate new findings and evolve its understanding at a pace that makes any summary a snapshot rather than a settled account. The picture of how each member of this family performs in human aging biology is still being drawn, and the evidence base across the family is growing year by year.
The Codeage approach to Cellular Longevity is built on this full context — not on a single molecule isolated from its family, but on the biological architecture of how the body produces and maintains NAD+ across a lifetime, and what the age-related changes to that architecture mean. The NAD+ decline article and the bioavailability article provide the surrounding context that makes the family comparison most meaningful.
The picture of how each member
of this family performs
in human aging biology
is still being drawn.
Codeage · Pillar 03 · Cellular Longevity
Built for the
cellular long game.
Cellular Longevity is Pillar 03 of The Longevity Code — the dimension of the system built around NAD+ biology, mitochondrial health, and the science of cellular aging.
Explore Cellular Longevity →
